Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Using microneedling with PRP improves skin and hair conditions more than microneedling alone.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The Hairless gene is crucial for hair cell development, affecting whether skin cells become hair or skin and oil gland cells.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Human alpha defensin 5 helps heal wounds, reduce bacteria, and grow hair on burned skin.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Fat cells are important for tissue repair and stem cell support in various body parts.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Azelaic acid treats acne, rosacea, and hyperpigmentation with minimal side effects.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Hydrogels could lead to better treatments for wound healing without scars.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.